Blog
RSS FeedPosted by Michael Wonder on 13 Oct 2021
SMC accepts Cabometyx/Opdivo combo for advanced kidney cancer patients
13 October 2021 - The SMC has recommended Cabometyx (cabozantinib) plus Opdivo (nivolumab) for use by via NHS Scotland for ...
Posted by Michael Wonder on 13 Oct 2021
Scotland is first country to offer free digital therapies to every adult
13 October 2021 - The Scottish Government has announced that all Scottish adults will now have access to "digital therapeutics" ...
Posted by Michael Wonder on 12 Oct 2021
SMC - October 2021 decisions
11 October 2021 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland has today ...
Posted by Michael Wonder on 13 Sep 2021
SMC - September 2021 decisions
13 September 2021 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 09 Aug 2021
Scotland backs Bavencio for bladder cancer after NICE says no
9 August 2021 - Patients with bladder cancer in Scotland will be the first in the UK to claim access ...
Posted by Michael Wonder on 09 Aug 2021
SMC - August 2021 decisions
9 August 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 14 Jul 2021
Kesimpta (ofatumumab) approved for relapsing remitting MS in Scotland
12 July 2021 - The SMC has recommended that Kesimpta can be prescribed for people with relapsing remitting multiple sclerosis who ...
Posted by Michael Wonder on 13 Jul 2021
Tecentriq, Kesimpta lead latest SMC decisions
13 July 2021 - The SMC has accepted three new medicines for use by NHS Scotland and rejected one in its ...
Posted by Michael Wonder on 12 Jul 2021
SMC - July 2021 decisions
12 July 2021 - The SMC has today published advice accepting three new medicines. ...
Posted by Michael Wonder on 07 Jun 2021
SMC - June 2021 decisions
7 June 2021 - Advice on five new medicines for use in conditions including advanced gastric cancer and chronic lymphocytic leukaemia ...
Posted by Michael Wonder on 13 May 2021
Pilot of new health technology evaluation process for antimicrobials
7 May 2021 - Research to develop novel antibiotics has in recent years been seen as commercially unattractive due to limited ...
Posted by Michael Wonder on 10 May 2021
Medicines for colorectal, skin and ovarian cancers approved for NHS Scotland use
10 May 2021 - The Scottish Medicines Consortium accepted a treatment of colorectal cancer in patients with a gene mutation called ...
Posted by Michael Wonder on 10 May 2021
SMC - May 2021 decisions
10 May 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has announced today that ...
Posted by Michael Wonder on 13 Apr 2021
Scotland opens door to Translarna for Duchenne muscular dystrophy
13 April 2021 - A disparity in UK access to a medicine for Duchenne muscular dystrophy has been addressed, after ...
Posted by Michael Wonder on 13 Apr 2021
Four medicines accepted for use by NHS Scotland
13 April 2021 - The Scottish Medicines Consortium has approved NHS funding for four new medicines, including treatments for multiple ...